KURA
Kura Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.25
+0.76%Leverage
- Debt / equity
- 0.50x
- Net debt / equity
- -0.95x
- Debt / assets
- 0.04x
- Debt / EBITDA
- -0.08x
- Net debt / EBITDA
- 0.16x
Liquidity & coverage
- Current ratio
- 4.73x
- Quick ratio
- 4.71x
- Cash ratio
- 4.39x
- Interest coverage
- -224.01x
- EBITDA / interest
- -205.90x
- Working capital
- $441.2M
Cash & dividend
- FCF / debt
- -4.80x
- Cash flow / debt
- -4.57x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026